会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MONOCLONAL ANTIBODY SPECIFIC TO BOTH HUMAN INTERFERON-ALPHA SUBTYPE ALPHA 8 AND ITS MUTANT PROTEINS
    • 人类干扰素ALPHA亚型ALPHA 8及其突变蛋白特异性单克隆抗体
    • US20110091968A1
    • 2011-04-21
    • US12933768
    • 2009-03-16
    • Shigeharu FukudaChie UshioHarumi AriyasuTohru KayanoToshio AriyasuTsunetaka Ohta
    • Shigeharu FukudaChie UshioHarumi AriyasuTohru KayanoToshio AriyasuTsunetaka Ohta
    • C07K16/24G01N33/566C07K1/22C12N5/16
    • C07K16/249A61K2039/505C07K2317/24C07K2317/56C07K2317/76G01N33/6866G01N2030/8831
    • The present invention has the first object to provide a monoclonal antibody specific to interferon α subtype α8 (IFNα8) and its mutant proteins, the second object to provide a hybridoma capable of producing the monoclonal antibody, the third object to provide a method for detecting the IFNα8 and its mutant proteins by the monoclonal antibody, the fourth object to provide a method for purifying the IFNα8 and its mutant proteins by the monoclonal antibody, and the fifth object to provide a therapeutic agent for treating diseases whose onsets or exacerbation are related with IFNα8. The present invention solves the above objects by providing a monoclonal antibody specific to IFNα8 and its mutant proteins, a hybridoma capable of producing the monoclonal antibody, a method for detecting the IFNα8 and its mutant proteins by immunoreaction using the monoclonal antibody, a method for purifying the IFNα8 and its mutant proteins using the monoclonal antibody, and a therapeutic agent for treating diseases whose onsets or exacerbation are related with IFNα8, which contains the monoclonal antibody as an effective ingredient.
    • 本发明的第一个目的是提供对干扰素α亚型α8(IFNα8)及其突变蛋白特异性的单克隆抗体,第二个目的是提供能产生单克隆抗体的杂交瘤,第三个目的是提供一种检测方法 通过单克隆抗体IFNα8及其突变蛋白,第四个目的是提供通过单克隆抗体纯化IFNα8及其突变蛋白的方法,第五个目的是提供一种用于治疗其发作或加重与IFNα8相关的疾病的治疗剂 。 本发明通过提供对IFNα8及其突变蛋白特异性的单克隆抗体,能够产生单克隆抗体的杂交瘤,通过使用单克隆抗体的免疫反应检测IFNα8及其突变蛋白的方法来解决上述目的,纯化方法 使用单克隆抗体的IFNα8及其突变蛋白,以及用于治疗其发作或恶化与IFNα8相关的疾病的治疗剂,其含有单克隆抗体作为有效成分。
    • 2. 发明授权
    • Monoclonal antibodies specific for human interferon-alpha subtype alpha 8
    • 对人类干扰素α亚型alpha 8具有特异性的单克隆抗体
    • US08357782B2
    • 2013-01-22
    • US12933768
    • 2009-03-16
    • Shigeharu FukudaChie UshioHarumi AriyasuTohru KayanoToshio AriyasuTsunetaka Ohta
    • Shigeharu FukudaChie UshioHarumi AriyasuTohru KayanoToshio AriyasuTsunetaka Ohta
    • C07K16/24A61K39/395C12N5/12
    • C07K16/249A61K2039/505C07K2317/24C07K2317/56C07K2317/76G01N33/6866G01N2030/8831
    • The present invention has the first object to provide a monoclonal antibody specific to interferon α subtype α8 (IFNα8) and its mutant proteins, the second object to provide a hybridoma capable of producing the monoclonal antibody, the third object to provide a method for detecting the IFNα8 and its mutant proteins by the monoclonal antibody, the fourth object to provide a method for purifying the IFNα8 and its mutant proteins by the monoclonal antibody, and the fifth object to provide a therapeutic agent for treating diseases whose onsets or exacerbation are related with IFNα8. The present invention solves the above objects by providing a monoclonal antibody specific to IFNα8 and its mutant proteins, a hybridoma capable of producing the monoclonal antibody, a method for detecting the IFNα8 and its mutant proteins by immunoreaction using the monoclonal antibody, a method for purifying the IFNα8 and its mutant proteins using the monoclonal antibody, and a therapeutic agent for treating diseases whose onsets or exacerbation are related with IFNα8, which contains the monoclonal antibody as an effective ingredient.
    • 本发明的第一个目的是提供对干扰素α亚型α8(IFNα8)及其突变蛋白特异性的单克隆抗体,第二个目的是提供能产生单克隆抗体的杂交瘤,第三个目的是提供一种检测方法 通过单克隆抗体IFNα8及其突变蛋白,第四个目的是提供通过单克隆抗体纯化IFNα8及其突变蛋白的方法,第五个目的是提供一种用于治疗其发作或加重与IFNα8相关的疾病的治疗剂 。 本发明通过提供对IFNα8及其突变蛋白特异性的单克隆抗体,能够产生单克隆抗体的杂交瘤,通过使用单克隆抗体的免疫反应检测IFNα8及其突变蛋白的方法来解决上述目的,纯化方法 使用单克隆抗体的IFNα8及其突变蛋白,以及用于治疗其发作或恶化与IFNα8相关的疾病的治疗剂,其含有单克隆抗体作为有效成分。